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Numerous studies have established  that  murine cytotoxic T  lymphocytes (CTL  1) 
recognize foreign antigens  (X) in a  restricted fashion  (1, 2).  Foreign antigens such as 
viral  proteins,  haptens,  minor  histocompatibility  antigens,  and  the  male  specific 
antigen  H-Y,  together  with  products  coded  for  by  the  major  histocompatibility 
complex (MHC), contribute to the antigenic  pattern  recognized by CTL.  It is well 
documented  that  the  K,  D,  or  L  gene products  of the  H-2 complex are  involved. 
However, the nature of the T  cell receptor that mediates this dual specificity is still 
unknown.  To  explain  the  phenomenon  of H-2  restriction,  two  models  have been 
proposed (3). The two-receptor model postulates that CTL possess two separate types 
of antigen binding sites, one for X  and one for self H-2 antigen. Evidence suggesting 
that it is the learning process during T  cell ontogeny in the thymus that determines 
the  self H-2  recognition  (4,  5)  strengthened  this  concept.  The  alternative  model 
postulates that there is only one binding site for a new antigenic determinant to which 
both antigen X  and a self H-2 antigen contribute. Adsorption experiments (6) indicate 
that for specific interaction between CTL and targets to occur, both antigens (i.e., self 
H-2 and antigen X) have to be displayed on the cell surface of targets, a  result that 
is consistent with the latter model. So far there is no conclusive evidence that excludes 
either model. 
The  present  experiments describe  a  different  approach to the problem. Antisera 
were raised against virus-immune CTL in an attempt to analyze the T  cell receptor 
by serological  means,  a  procedure  that  has  proved  to  be  very useful  for studying 
lymphocyte receptors.  Anti-idiotypic  (anti-id)  reagents  directed  against  cell-bound 
receptor molecules  defined  receptor  idiotypes on  alloreactive T  cells  (7,  8)  and  on 
trinitrophenyl  (TNP)-speeific CTL  (9).  Initially,  it  was not  clear whether a  similar 
procedure would yield anti-id sera against virus-immune CTL, mainly because it was 
assumed  that  an anti-viral CTL response might be too heterogeneous to allow the 
detection  of such  determinants  on CTL generated  in  batch cultures.  However, the 
present  data  indicate  that  antibodies  raised  in  syngeneic  mice recognize  idiotypic 
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determinants on  virus-immune CTL.  The  relevance to  the  two  models  for  MHC- 
restricted CTL will be discussed. 
Materials and Methods 
Animals.  CBA (H-2k), B10.ScSn (B10) (H-2b), and BALB/c (H-2  d) mice were provided by 
the Animal Breeding Unit of the Imperial Cancer Research Fund, Mill Hill, London. B 10.HTG 
(H-2  g) mice were obtained from OLAC, Bicester,  Oxon, England. In all experiments,  i animals 
of the same sex were used. 
Viruses and Immunization.  Newcastle disease  virus (NDV) strain Ulster and influenza virus 
strain A/X31 were grown and titrated as described previously (10, 11). Mice were immunized 
with 2 ×  107 egg infectious dose (EIDs0) U of NDV or influenza virus strain A/X31. Spleen 
cells from these donors were used as responder cells for in vitro responses. A hyperimmune anti- 
NDV serum was generated by injecting mice at monthly intervals with 3 ×  107 EIDso U  of 
NDV. 
Generation of Virus-immune CTL.  The method for influenza-immune  CTL has been reported 
(12). Similarly, NDV-immune CTL were generated in vitro by culturing responder spleen cells 
from  mice  immunized with  NDV  3-12  wk  previously with  normal syngeneic spleen cells 
infected with 1-2 EID~0 U of NDV per nucleated cell (stimulator cells). 8 ×  10  7 responder cells 
were cultured with 2 ×  107 stimulator cells in 40 ml of RPMI-1640 medium (Grand Island 
Biological Co., Grand Island, N. Y.) supplemented with 10% heat-inactivated fetal calf serum 
(FCS), 10  -4 M 2-mercaptoethanol, and antibiotics. Cells were grown in tissue culture flasks (75- 
cm  2 growth area, Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.) incubating 
at 37°C in an atmosphere of 5% COz and harvested after 5 d. 
Mixed Lymphocyte Cultures (MLC).  Primary MLC used splenic responder cells and gamma- 
irradiated (2,000 rad) allogeneic splenic stimulator cells cultured at 37°C for 5 d at a responder: 
stimulator ratio of 1:1. 
Cytotoxicity Assays  with Macrophage Target Cells.  The method has been described in detail 
elsewhere  (13). The multiplicity of infection for  NDV and influenza X31  was  1 EIDso/cell. 
Targets were infected for 1.5 h at 37°C. Serial dilutions of Ficoll-Isopaque-purified  CTL (14) 
were added after a  further incubation time of 1 h at 37°C. Percent specific  51Cr release was 
calculated using the formula: 
experimental -  spontaneous release 
x  100. 
total release -  spontaneous release 
Spontaneous release did not exceed 20% in any experiment and was usually < 10%. Data given 
are the means of triplicates for assays run at 37°C for 5-8 h. SEM were usually <+3% and are 
omitted for clarity. 
Cytotoxicity Assay Using EL4 (H-2  b) BW5147 and L929 (Both H-L#)  Target Cells.  The method 
that has been described for influenza virus-infected cells (12) was also used for NDV-infected 
cells. 
Generation and Purification of CTL for Immunization.  Cultures were set up as described above, 
except that gamma-inactivated NDV was used (1.5 ×  106 rad) and cells were grown in Iscove's 
modified Dulbeceo's medium (Grand Island Biological Co.) supplemented with normal mouse 
serum (NMS) from syngeneic mice instead of FCS. These mouse sera were freshly collected and 
heat inactivated and were used at 0.5% for CBA cultures or  1% for B10.ScSn (B10) cultures. 
Cells were harvested 5 d later in serum-free medium, purified over Ficoll-Isopaque and washed 
five times in medium containing no serum. 
Immunization  with  NDV-immune  CTL.  CBA and B10  mice were  injected intraperitoneally 
with  1 ×  10  7 syngeneic NDV-immune CTL. Five injections were given at 2-wk intervals, the 
first  in  complete  Freund's adjuvant, and  booster  injections in  incomplete adjuvant. Test 
bleedings were carried out  10 d after the fifth injection. Sera from individual mice were heat 
inactivated (30 min at 56 °C), absorbed twice on syngeneic spleen cells (10  s cells/ml antiserum), 
and screened for  the  presence of anti-id antibodies in an indirect radioimmunoassay. Mice 
producing anti-id antibodies were given another injection of CTL and their sera were collected 
10 d later. These sera were treated as indicated above and stored in aliquots at -20°C. 1564  IDIOTYPES ON  VIRUS-IMMUNE CYTOTOXIC  T  LYMPHOCYTES 
Treatment of CTL with Antisera.  Suspensions of CTL (4 ×  l0  s cells/ml) were incubated for 45 
min at 4°C in medium containing antisera (Hepes-buffered minimal essential medium supple- 
mented with 5% heat-inactivated FCS). A monoclonal anti-Thy-l.2 (15), a hyperimmune anti- 
NDV  serum,  and anti-id sera under test were diluted to  1:500,  1:20,  and  1:20,  respectively. 
Cells were washed  tice and  incubated  for 60  min  at  37°C  with  a  selected batch  of rabbit 
complement at a  final dilution of 1:15.  Finally, cells were washed twice and tested in a  ~ICr 
release assay. Effector:target cell ratios in figures and tables are based on NMS controls. 
Indirect Radioimmunoassay with  CTL  as  Target Cells.  The  indirect  binding  assay  with  r~sI 
F(ab')2 sheep  anti-mouse Ig  (16)  was  adapted  to  virus-immune  CTL  as  target  cells. The 
following modifications were made. The microtiter plates (Cooke disposable flexi-plates "U" 
M24; Cooke Engineering Co., Alexandria, Va.) were preincubated with 150 tal FCS/well for 1 
h at 37°C and then washed three times with medium. Before the test, CTL were purified on 
Ficoll-Isopaque. The number of cells per well was decreased to 1 X  10  ~ or 5 X  104, and both 
incubations were carried out at room temperature. The input of 125I F(ab')2 was 25,000 cpm/ 
well. The medium contained 10  -2 M  NaNa. Serial dilutions of individual sera were tested. As 
controls, anti-H-2  b serum  (D.33)  or anti-H-2  k serum  (D.32)  from  the  National  Institute of 
Allergy and Infectious Diseases, Bethesda, Md. were included in the test. 
Results 
Experimental System.  To  reduce  the heterogeneity of CTL  generated  upon stimu- 
lation with  virus-infected cells, a  virus with  a  small number  of surface proteins was 
selected. NDV  is a  paramyxovirus and codes for only two surface glycoproteins. The 
avirulent strain Ulster was chosen because cultured mammalian cells are nonpermis- 
sive (10)  for this strain, an important prerequisite for avoiding the generation of anti- 
NDV  antibodies in mice immunized with NDV-immune  CTL. 
Specificity  of Virus-immune  CTL.  To  investigate the specificity of secondary NDV- 
immune CTL, spleen cells from NDV-primed CBA and B10 mice were restimulated 
in vitro with NDV-infected syngeneic stimulator cells. These secondary effector cells 
fulfill all requirements for an H-2 restricted CTL response (Ursula Kees, manuscript 
in preparation). 
Treatment  of effector  cells  with  anti-Thy-l.2  and  complement  abrogates  their 
capacity to lyse syngeneic NDV-infected target cells. Fig.  1 shows the activity of B 10 
anti-B 10 NDV CTL with or without anti-Thy-1.2 treatment assayed on NDV-infected 
EL4 target cells. 
For lysis to occur, effector and target cells have to share the H-2K or H-2D region 
of the  gene  complex.  CBA  anti-CBA  NDV  CTL  lyse  NDV-infected  macrophages 
from  CBA  mice,  whereas  allogeneic  NDV-infected  target  cells  are  not  recognized 
(Table I). Conversely, BALB/c anti-BALB/c NDV  CTL  lyse only syngeneic NDV- 
infected target cells. Thus,  allogeneic NDV-infected CBA or B10 cells are not lysed, 
but cells from B10.HTG mice that share with BALB/c only the K and I regions of the 
H-2 gene complex are lysed very efficiently. 
To test for virus specificity, CBA anti-CBA NDV CTL were compared with CBA 
anti-CBA  X31  CTL.  Both  effector  populations  were  assayed  on  NDV-  and  X31- 
infected  L929  cells.  The  results  shown  in  Fig.  2  indicate  that  these  two  effector 
populations do not  cross-react, although  the viruses used  for stimulation are closely 
related. 
Analysis  of Anti-id Sera  in  Binding  Tests.  To  raise  antisera  against  NDV-immune 
CTL, a  number of immunization schemes were compared. Cell doses ranged from  10  6 
to 2  ×  10  7 per injection. CTL were given at various intervals and by different routes 
of  injection.  Several  measures  were  taken  to  reduce  the  generation  of  anti-virus URSULA R. KEES  1565 
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Fro.  1.  Effect of Thy-l.2 treatment on cytotoxic activity of B10 anti-B10  NDV CTL assayed on 
NDV-infected EL4  target  cells.  CTL  were  untreated  (---), treated with  NMS and complement 
(...), or treated with Thy-l.2 and complement (--). 
TABLE  I 
1-1. 2 Restriction  of ND V-immune  CTL Generated In  Vitro 
CTL:~  e:t 
Cytotoxicity on NDV-infected target cells* 
CBA (kkk)  B10 (bbb)  BALB/c  B10.HTG 
(ddd)  (ddb) 
BALB/c (H.2  d)  h 1  0.1  6.8  21.0  28.2 
3:1  6.9  10.2  45.9  54.7 
9:1  12.6  5.6  71.6  58.1 
CBA (H.2 k)  1:1  13.6  4.7  0  0 
3:1  34.6  8.2  4.3  11.3 
9:l  49.7  6.0  5.7  4.7 
* Percent 51Cr release from NDV-infected macrophage target cells over an 8-h period with 
release from uninfected controls subtracted. Means of triplicates are given with SEM never 
larger than 2.4. I-1.2 maps in brackets are for K, 1, and D regions of the gene complex. 
~: Effector cells were generated against syngeneic NDV-infected stimulator cells and tested at 
the indicated effector:target ratio. 
antibodies in mice immunized with CTL. For the generation of CTL, virus inactivated 
by gamma  irradiation was used for stimulation and stimulator cells were washed three 
times before use  in cultures.  Furthermore,  CTL  were washed thoroughly to prevent 
the carry-over of virus  particles  into  recipient  mice.  Positive sera  were obtained  as 1566 
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F~o.  2.  Virus specificity of NDV- and X31-immune CTL. CBA anti-CBA NDV CTL (---) and 
CBA anti-CBA X31 CTL (--) were assayed on NDV-infected L929 target  cells (left panel) and on 
X31-infected  L929 target cells (right panel). 
follows. CBA and B10 mice were injected intraperitoneally with 107 purified syngeneic 
NDW-immune  CTL  Injections were  given at  2-wk  intervals,  the  first  in  complete 
Freund's adjuvant.  Mice were  bled  10  d  after  the  fifth  injection (see  Materials and URSULA  R.  KEES  1567 
Methods). After absorption on syngeneic spleen cells, these sera were screened for the 
presence of anti-id antibodies in an indirect binding assay. Analysis was carried out 
on NDV-immune CTL of the type used for immunization. Controls included alloge- 
neic CTL generated against the same virus and normal spleen cells from both strains 
of mice. Results in Table II illustrate the binding pattern of two sera from B10 mice. 
Only serum B10-83 showed specific binding to B 10 anti-B 10 NDV CTL. 
Specific binding to relevant CTL as shown in this case was obtained with very few 
sera. Out of 38 CBA and 44 B 10 mice immunized as described above, only three mice 
gave a detectable response. 
Functional Analysis of Anti-id Sera.  Sera showing specific binding to the CTL type 
used  for immunization were subjected  to  a  functional test.  They were  assayed for 
their  capacity to  reduce  the  cytotoxic activity  of CTL of the  relevant  type.  Two 
different tests were carried out. The first  involved assessment of the blocking capacity 
of these anti-id sera.  The cytotoxicity of B10 anti-B10 NDV CTL was measured in 
the presence of sera B 10-83 and B 10-93 (both sera were positive in an indirect binding 
assay). Dilutions ranging from 1:10 to  1:100 did not reveal any reduction of cytotox- 
icity in comparison with CTL assayed in the presence of NMS (data not shown). 
For the second test,  CTL were treated  with  anti-id sera and complement. Their 
cytotoxicity was subsequently measured in a  routine 51Cr release assay. Cells treated 
with NMS and complement served as controls. Table III lists  the results from three 
experiments.  Serum B10-93 reduced the cytotoxicity of B10 anti-B10 NDV CTL by 
46.5%  in experiment  1 and by 66.8%  in experiment 2. The cytotoxicity of CBA anti- 
CBA NDV CTL was not affected after treatment with this serum.  Similarly, serum 
B10-83  consistently  reacted  with  B10  CTL  and  not  with  CBA CTL.  In  contrast, 
serum CBA-113 had the reverse effect (experiment 3). The cytotoxicity of CBA anti- 
CBA NDV CTL was reduced by 91.8%, whereas no significant reduction was obtained 
after treatment  of allogeneic CTL specific for the same virus. These results suggest 
that  the reactivity of the three antisera tested  was directed  against  idiotypic deter- 
minants  on  CTL.  However,  the  possibility  that  viral  determinants  on  CTL  were 
recognized had  to  be  considered.  Both types of CTL used  in  experiments  listed  in 
Table  III were  generated  under  identical  conditions and  therefore  have  an  equal 
TABLE  II 
Binding Activity of Anti-id Sera in Indirect Radioimmunoassay 
Target cells* 
Sera:~  BALB/c anti-  BALB/c 
B10 anti-Bl0 NDV  B10  BALB/c NDV 
Anti-H.2  b  335 ±  22§  350 ±  18§  216 ±  11  220 ±  16 
As B10-83  398 ±  15§  172 ±  11  220 +  14  240 ±  17 
As B10-84  93 ±  18  139 ±  15  195 ±  16  189 ±  16 
NMS  106 ±  10  144 ±  16  208 ±  19  203 ±  12 
* Binding assay was carried out on  l0  s normal spleen cells from B10 and BALB/c mice and on  l0  s CTL 
generated in vitro. CTL were active in a 5tCr release assay on syngeneic NDV-infected target cells. Data 
given are cpm bound (triplicates). 
:~ Antisera B10-83 and B10-84 were from two B10 mice immunized with BI0 anti-B10 NDV CTL.  Anti- 
H.2  b serum  was serum  D.33  obtained from  the National Institute of Allergy and  Infectious Diseases, 
Bethesda, Md. All sera were tested at a  l: 100 dilution. 
§ Significantly more binding than NMS control on the same target cells (P <  0.001) 1568  IDIOTYPES ON VIRUS-IMMUNE  CYTOTOXIC  T  LYMPHOCYTES 
TAaLE III 
ND V-immune CTL Treated with Anti-id Sera and Complement 
CTL:B 10 anti-B 10  CTL:CBA anti-CBA 
NDV*  NDV 
Percent  ~Cr release of target  Percent  Treatment of CTL  5aCr rclease of target  reduction  reduction 
cells:l:  cells 
B10  B10 NDV  CBA  CBA NDV 
Experiment 1 
NMS + c'  3.7  41.3  0  7.8  32.3  0 
As B10-93 + c'§  NTII  22.1  -46.5  NT  34.5  +6.8 
Experiment 2 
NMS + c'  2.8  49.7  0  2.3  30.3  0 
As B10-83 + c'  NT  19.4  -61  NT  36.6  +20.8 
As B10-93 + c'  NT  16.5  -66.8  NT  32.6  +7.6 
Experiment 3 
NMS + c'  7.9  51.6  0  5.7  45.1  0 
As B10-83 + c'  NT  16.6  -67.8  NT  44.1  -2.2 
As CBA-113 + c'  NT  48.8  -5.4  NT  3.7  -91.8 
* Effector cells were generated in vitro and tested at an effector:target ratio of 5:1. 
1: Percent SlCr release from macrophage target ceils over a 5-h period. Means of triplicates are given with 
SEM never >2.1. 
U Not tested. 
§ All antisera were used at a 1:20 dilution. 
chance of displaying viral determinants. Because sera from B 10 and CBA mice reacted 
specifically  with  their  relevant  CTL,  the  likelihood  that  viral  determinants  are 
recognized  is  minimal. To  further  test  this  possibility,  an  additional  group  was 
included in  all  subsequent experiments.  NDV-immune CTL  were  treated  with  a 
hyperimmune anti-NDV serum plus complement. No reduction of cytotoxicity was 
observed  in any experiment, indicating that  the  putative anti-id sera were  indeed 
directed toward determinants associated with the recognition site on CTL. 
The results in Table III indicate that the proportion of CTL susceptible to lysis by 
a given anti-id serum was variable. This observation was confirmed by comparing the 
reduction of cytotoxicity of CBA anti-CBA NDV CTL after treatment with serum 
CBA-113 plus complement in three additional experiments. This serum consistently 
reduced the cytotoxicity of the relevant CTL. The effect, however, ranged from 45.2% 
reduction (experiment 2 in Table IV) to 91.8% reduction (experiment 3 in Table III). 
These  values  for  the  reduction  of  the  cytotoxicity  are  based  on  the  cytotoxicity 
measured for one effector:target ratio (see tables). A 5-h assay time for the cytotoxicity 
assay insures that the plateau level of ~1 Cr release is not yet reached. 
Specificity  ofAnti-id Sera.  To further investigate the specificity of these anti-id sera, 
antiserum CBA-113 was  tested on a  panel of CTL populations. Besides CBA anti- 
CBA  NDV  CTL  (cells used  for  immunization), syngeneic CTL  directed  toward  a 
different virus (CBA anti-CBA X31) and CTL activated in an MLC (CBA anti-B10) 
and (as before) allogeneic CTL directed toward the same virus (B10 anti-B10 NDV) 
were  included.  After  treatment  with  serum  CBA-113,  anti-Thy-l.2, hyperimmune 
anti-NDV, or NMS and complement, the cytotoxicity of the four CTL populations URSULA R.  KEES 
TABLE  IV 
NDV-immune CTL Treated with Anti-id Serum CBA-I I3 and Complement 
1569 
Treatment of CTL 
CTL:B 10 anti-B 10  CTL:CBA anti-CBA 
NDV*  NDV 
Percent  5]Cr release of target  51Cr release of target  reduction 
cells:]:  cells 
B10  B10 NDV  CBA  CBA NDV 
Percent 
reduction 
Experiment 1 
NMS +  c'  6.2  70.3 
as CBA-113 +  c'§  NT[I  69.6 
Experiment 2 
NMS +  c'  NT  NT 
as CBA-113 +  c'§  NT  NT 
0  2.1  29.1  0 
-- 1.0  NT  15.9  -45.4 
5.4  68.9  0 
NT  37.1  -45.2 
* Effector cells were generated in vitro. 
:~ Percent 51Cr release from  macrophage target  cells  over a  5-h period.  Effector:target ratio was 4:1. 
Means of triplicates are given with SEM never >2.8. 
§ Antiserum CBA-113 was used at a  1:20 dilution. 
II Not tested. 
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FIG.  3.  Cytotoxicity of four different CTL  populations tested on  appropriate target cells  after 
treatment with anti-id serum CBA-113 and complement (...), NMS and complement (---), serum 
CBA-113 alone (..), or left untreated (--). 
was  measured  on  their  appropriate  target  cells.  Anti-NDV  serum  did  not  have  an 
effect on the cytotoxicity of any of the CTL  populations  under  test, whereas treatment 
with anti-Thy-1.2  abrogated  the cytotoxicity of all four populations  (data not shown). 
As shown  in Fig.  3A, significant reduction  of cytotoxic activity was observed for CBA 
anti-CBA  NDV  CTL  treated  with  serum  CBA-113.  Syngeneic  CTL  with  different 
specificities (CBA anti-CBA  X31  and  CBA  anti-B10)  were not affected  (Fig.  3D and 1570  IDIOTYPES ON VIRUS-IMMUNE CYTOTOXIC  T  LYMPHOCYTES 
B).  A  marginally  reduced  cytotoxicity was measured  for B10  anti-B10  NDV CTL 
after treatment with serum CBA-113  (Fig. 3C). Out of eight experiments carried out 
with serum CBA-113,  this was the only one in which an effect on allogeneic NDV- 
immune CTL could be demonstrated. 
Discussion 
Experiments  presented  in  this  communication  demonstrate  that  anti-id  antisera 
can be generated against virus-immune CTL. Although antigen-binding receptors on 
T  cells have been extensively studied on alloreactive and TNP-immune CTL (7, 8), 
this  work has now been  extended  to  virus-immune CTL that  can  he  generated  in 
vitro  but  that  also  occur  naturally.  The  fact  that  specificity-associated  (idiotypic) 
determinants can be detected on CTL generated in batch cultures indicates that the 
response is less  heterogeneous than  initially assumed. The observation that all three 
antisera under test reproducibly reduced the cytotoxicity of the relevant CTL by at 
least 45% seems to indicate that a relatively small number of different CTL clonotypes 
are present in batch cultures, rather than a broad spectrum of clonotypes. 
The  immunization  protocol used  here to produce antisera  against  virus-immune 
CTL  is  similar to  the  ones  employed  to  generate  antisera  against  alloreactive and 
TNP-immune CTL. The finding that  the incidence of positive sera is very low is in 
agreement  with  reports  from other  investigators  using  similar  procedures  (17,  18). 
Although  a  number of different  immunization protocols have been tested  for virus- 
immune CTL, it may be that the optimal scheme has yet to be found. The possibility 
remains  that  recipients  immunized  with  syngeneic  CTL  exercise  strict  regulatory 
control over such responses. 
The three antisera shown to bind specifically to CTL used for immunization were 
examined  for their  functional  properties.  Blocking  studies  were  carried  out  under 
conditions in which CTL were preincubated with anti-id antiserum, leaving the CTL 
in contact  with  the antiserum  during  the entire assay period.  It was found that  no 
reduction of cytotoxicity could be observed for any of the three antisera in a  total of 
six experiments. It is possible that the titer of the antibody was not high enough for 
effective blocking.  Furthermore,  the affinity of the anti-id  antibody to the  receptor 
structure might be lower than the affinity of the receptor structure to the target cell. 
Similarly, unsuccessful blocking experiments have been reported using conventional 
antisera  against  T  cell  markers.  However, in  recent  studies  using  monoclonal  anti- 
Lyt-2 antibodies,  (19)  inhibition  of T  cell function  could be shown,  indicating  that 
highly specific high titer antibodies might be required for blocking experiments. 
In contrast to these blocking studies, the cytotoxicity of virus-immune CTL could 
be reduced  by treatment  of CTL with  the  same anti-id  antisera  and  complement 
before  the  cytotoxicity  assay.  Specificity  tests  carried  out  with  a  CBA  antiserum 
(raised against CBA anti-CBA NDV effector cells) show discrimination between CTL 
used for immunization and syngeneic CTL generated against a  different virus (CBA 
anti-CBA X31),  or allogeneic effector cells  (CBA anti-B10),  as well as effector cells 
from H-2 different strains generated against the same virus (e.g., B 10 anti-B 10 NDV). 
This  result  indicates  that  MHC-restricted  CTL  carry  distinct  idiotypes  on  their 
surface. A  suggestion  for cross-reactive idiotypes was found in only one out of eight 
experiments,  where  antiserum  CBA-113  reduced  the  cytotoxicity  of B10  anti-B10 
NDV CTL to a small extent. URSULA R.  KEES  1571 
Similar results have been reported for TNP-immune CTL where antisera raised in 
AKR mice could be shown to contain  activity against idiotypic determinants on T 
cell receptors of H-2-restricted  AKR anti-AKR-TNP CTL  (9).  It should  be noted, 
however, that the CTL response to viral antigens can be more stringently defined as 
being directed against a foreign antigen in the context of self H-2. Forman and Klein 
(20)  reported that TNP-immune CTL of wild type H-2I~ cross-react on target cells 
with mutant H-2I¢  'a plus TNP. This is in contrast to viral systems in which specificity 
is  maintained  between  H-2K  b  and  H-2K  b~  (21,  22).  The  cross-reactivity  pattern 
observed  for TNP-immune  CTL  appears  to  support  the  notion  that  the  in  vitro 
response to TNP self is similar to responses to allogeneic stimulators, possibly because 
H-2 antigens themselves are employed in the haptenation procedure (23, 24). 
Based on the results presented in this report, is it possible to discriminate between 
a one-receptor and a two-receptor model for MHC-restricted CTL? The finding that 
distinct idiotypes were found on H-2-different CTL generated against the same virus 
is consistent with one receptor or with two closely associated receptors on CTL. In the 
latter  case,  one  would  have  to  postulate  that  the  anti-id  antibodies  recognized 
determinants forming the junction zone between the two receptors. Because it is not 
known  whether  the  postulated  anti-self receptor  on  CTL  is  immunogenic,  a  two- 
receptor  model  cannot  be excluded.  However,  to  accommodate  the  reported  data 
would mean postulating a nonoverlapping set of anti-viral receptors on H-2-disparate 
CTL. 
Summary 
Specificity-associated determinants could be demonstrated on major histocompat- 
ibility complex (MHC)-restricted virus-immune cytotoxic T  lymphocytes (CTL) using 
antisera raised in syngeneic mice. This result indicates that the number of clonotypes 
in a  CTL response against Newcastle disease virus (NDV)-infected syngeneic cells is 
sufficiently small to allow the detection of such idiotypic determinants. The functional 
properties  of three  anti-idiotypic  antisera  were  tested  in  blocking  studies  and  by 
measuring  the  reduction  of cytotoxic  activity  of CTL  after  treatment  with  anti- 
idiotypic  antisera  plus  complement.  Whereas  the  former  test  did  not  reveal  any 
inhibition of the T  cell function, the reactivity pattern of the latter test confirmed the 
results obtained from binding studies, i.e., all three anti-idiotypic antisera specifically 
reacted with CTL of the type used for immunization and had no effect on syngeneic 
influenza-immune CTL, syngeneic alloreactive CTL, or NDV-immune CTL of an H- 
2-disparate strain.  These results are discussed  in terms of current  models for MHC- 
restricted CTL responses. 
The author wishes to thank Professor N. A. Mitchison, Dr. M. Cecka, Dr. A. M~illbacher,  and 
Dr. D. Waterfield for many helpful discussions, and Dr. Crecka and Dr. Waterfield for critical 
review of this manuscript. The skilled  technical assistance  of Miss Karen Abrams and Miss 
Anne Pether is gratefully acknowledged. 
Received  for publication 5January  1981. 
References 
1.  Doherty, P. C., R. V. Blanden, and R. M. Zinkernagel. 1976. Specificity  of virus-immune 
effector T  cells  for H-2K or H-2D compatible interactions:  implications for H-antigen 
diversity.  Transplant. Rev. 29:89. 1572  IDIOTYPES ON  VIRUS-IMMUNE CYTOTOXIC  T  LYMPHOCYTES 
2.  Shearer,  G.  M.,  T.  G.  Rehn,  and  A.  Schmitt-Verhulst.  1976. Role  of murine  major 
histocompatibility complex in the specificity of m vitro T cell-mediated lympholysis against 
chemically modified autologous lymphocytes. Transplant. Rev. 29:222. 
3.  Zinkernagel, R. M., and P. C. Doherty.  1974. Immunological surveillance against altered 
self components  by  sensitized  T  lymphocytes  in  lymphocytic choriomeningitis.  Nature 
(Lond.).  251:547. 
4.  Zinkernagel, R.  M., G.  N.  Callahan, A. Ahhage, S.  Cooper, P.  A. Klein, and J.  Klein. 
1978. On the thymus in the differentiation of "H-2 self-recognition" by T  cells: evidence 
for dual recognition?J. Exp. Med. 147:882. 
5.  Bevan,  M.  J.  1977. In  a  radiation  chimaera,  host  H-2  antigens  determine  immune 
responsiveness of donor cytotoxic cells. Nature (Lond.).  269.417. 
6.  Kees, U., A. Miillbacher, and R. V. Blanden.  1978. Specific adsorption of H-2-restricted 
cytotoxic T  cells to macrophage monolayers. J. Exp. Med. 148:1711. 
7.  Binz,  H.,  and  H.  Wigzell.  1977. Antigen-binding,  idiotypic T-lymphocyte  receptors. 
Contemp. Top. Immunobiol. 7:113. 
8.  Krammer, P. H. The T  cell receptor problem. Curr. Top. Microbiol. Immunol. In press. 
9.  Krammer,  P.  H.,  R.  Rehberger,  and  K.  Eichmann.  1980. Antigen receptors on  major 
histocompatibility complex-restricted T  lymphocytes. I. Preparation and characterization 
of syngeneic antisera against trinitrophenyl-activated T  cell blasts and demonstration of 
their specificity for idiotypes on cytotoxic T  lymphocytes.J. Exp. Med. 151:1166. 
10.  Nagai, Y., H.-D. Klenk, and R. Rott.  1976. Proteolytic cleavage of the viral glycoproteins 
and its significance for the virulence of Newcastle disease virus.  Virology. 72:494. 
11.  Braciale, T.J.  1977. Immunologic recognition of influenza virus-infected cells. I. Generation 
of a  virus-strain specific and  a  cross-reactive subpopulation of cytotoxic T  cells in  the 
response to type A influenza viruses of different subtypes. Cell. Immunol. 33:423. 
12.  Yap,  K.  L., and G.  L. Ada.  1977. Cytotoxic T  cells specific for influenza virus-infected 
target cells. Immunology. 32:151. 
13.  Blanden, R. V., M. B. C. Dunlop, P. C. Doherty, H. I. Kohn, and I. F. C. McKenzie. 1976. 
Effects of four H-2K mutations on virus-induced antigens recognized by cytotoxic T  cells. 
Immunogenetics. 3:541. 
14.  Davidson, W. F., and C. R. Parish. 1975. A procedure for removing red cells and dead cells 
from lymphoid celt suspensions. J. Immunol. Methods. 7:291. 
15.  Lake, P., E. A. Clark, M. Khorshidi, and G. H. Sunshine.  1979. Production and character- 
ization of cytotoxic Thy-1 antibody-secreting hybrid cell lines. Detection of T  cell subsets. 
Eur. J.  Immunol. 9:875. 
16.  Beverley, P. C. L.  1980. Production and use of monoclonal antibodies in transplantation 
immunology. In Transplantation and Clinical Immunology XI. J. L. Touraine, J. Traeger, 
H. Betuel, J.  Brochier, J. M. Dubernard, J. P. Revillard, and R. Triau, editors. Excerpta 
Medica, Amsterdam. 87. 
17.  Binz, H., H. Frischknecht, F. W. Shen, and H. Wigzell. 1979. Idiotypic determinants on T 
cell subpopulations.J. Exp. Med. 149:910. 
18.  Eichmann, K. 1978. Expression and function of idiotypes on lymphocytes. Adv. Immunol. 26: 
195. 
19.  Hollander, N., E. Pillemer, and I. Weissman. 1980. Blocking effects of Lyt-2 antibodies on 
T  cell functions. J. Exp. Med. 152:674. 
20.  Forman, J., and J. Klein. 1977. Immunogenetic analysis of H-2 mutations. VI. Crossreac- 
tivity in cell-mediated lympholysis between TNP-modified cells from H-2 mutant strains. 
Immunogenetics. 4:183. 
21.  Kees, U., and R. V. Blanden.  1976. A single genetic element in H-2K affects mouse T  cell 
antiviral function in pox virus infection.J. Exp. Med. 143:450. 
22.  Zinkernagel, R. M.  1976. H-2 compatibility requirement for virus-specific T  cell-mediated URSULA R. KEES  1573 
cytolysis. The H-2K structure involved is coded for by a single cistron defined by B6(Hzl) 
and B6(Hzl70)H-2K  b mutant mice.J. Exp. Med. 144:933. 
23.  Miillbacher, A., and R. V. Blanden.  1979. Cross-reactivity patterns of murine cytotoxic T 
lymphoeytes. Cell Immunol. 43:70. 
24.  Hiinig, T., and M. J. Bevan.  1980. Specificity of cytotoxic T  cells from athymic mice. J. 
Exp. Med. 152:688. 